A Randomized, Open-label, Single-center, Parallel Study in Subjects With Normal or Elevated Low-density Lipoprotein Cholesterol Level to Compare the Pharmacokinetics and Pharmacodynamics of the Two Formulations of QLC7401 Injection
Latest Information Update: 29 Jul 2025
At a glance
- Drugs RBD-7022 (Primary)
- Indications Hyperlipidaemia
- Focus Pharmacokinetics
- Sponsors Qilu Pharmaceutical
Most Recent Events
- 29 Jul 2025 New trial record